The mutations in FTLD genes, GRN, C9ORF72, and MAPT, have been described in clinical AD cohorts or in pedigrees with clinical phenotypes of AD (Brouwers et al., 2007; Cacace et al., 2013; Rademakers et al., 2003). This evidence concerns the gene C9orf72 and Alzheimer disease.